Tag: Pembrolizumab chemoradiotherapy approval

Home / Pembrolizumab chemoradiotherapy approval

Categories

Pembrolizumab with chemoradiotherapy is approved by the USFDA for FIGO 2014 Stage III-IVA cervical cancer

The Food and Drug Administration authorized pembrolizumab (Keytruda, Merck) in combination with chemoradiotherapy (CRT) for patients with FIGO 2014 Stage III-IVA cervical cancer on January 12, 2024.A...
pembrolizumab-chemoradiotherapy-approval

Scan the code